Castoro SPRL
The score of Castoro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets -6 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Castoro's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 10,543 € | ||||
| Equity | 27,290 € | ||||
| Cash | 38,025 € | ||||
| EBITDA | 16,262 € | ||||
| Total assets | 213,183 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Castoro's financial analysis
- Solvency12.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Castoro
Castoro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0826.851.655
- VAT number
- BE0826851655
- Peppol
- Registered · 0208:0826851655 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Jun 2010
- Registered office
- 1570 Pajottegem
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Castoro (SPRL) has been based in Pajottegem since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,543 € and equity of 27,290 €; its revenue is not published. Its solvency stands at 12.8%, below the median of its sector (44.2%).
Companies similar to Castoro
Companies in the same business, of comparable size and area, outside its group.
- LE Lumeçon Retail sale of pharmaceutical products Brussels · balance sheet 213,394 €
- Pharmacie LERICHE Retail sale of pharmaceutical products Florennes · balance sheet 213,898 €
- Amboplus Retail sale of pharmaceutical products Knokke-Heist · balance sheet 212,418 €
- Apotheek Sophie Vandewynckele Retail sale of pharmaceutical products Eeklo · balance sheet 214,484 €
- MDB Pharma Retail sale of pharmaceutical products Ghent · balance sheet 214,811 €
- Pharmasolutions Retail sale of pharmaceutical products Linkebeek · balance sheet 215,436 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
- Phidelta Pharma Retail sale of pharmaceutical products Liège · balance sheet 216,336 €
Frequently asked questions about Castoro
What is the revenue of Castoro?
Castoro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Castoro?
In Belgium, the VAT number is the company number prefixed with BE: BE0826851655 for Castoro, if the company is VAT-registered. Its company number (CBE) is 0826.851.655.
Where is the registered office of Castoro?
According to the CBE register, the registered office of Castoro is in 1570 Pajottegem.
What is the equity of Castoro?
At the close of the 2025 financial year, the equity of Castoro amounts to 27,290 €, a solvency of 12.8% of total assets.
Who manages Castoro?
The register lists 2 active mandates at Castoro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Castoro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →